Table 1.
Overview of clinical and histopathologic characteristics of samples
| Total | HPV Positive | HPV Negative | |
|---|---|---|---|
| Pt. (No.) | 120 (100%) | 51 (42.5%) | 69 (57.5%) |
| Age (Year) | 56.72 | 56.69 | 56.75 |
| *Gender (No.) | |||
| Female | 24 (20.0%) | 4 (3.3%) | 20 (16.7%) |
| Male | 96 (80.0%) | 47 (39.2%) | 49 (40.8%) |
| ***Anatomic Site (No.) | |||
| OROPHARYNX | 67 (55.8%) | 47 (39.2%) | 20 (16.6%) |
| ORAL CAVITY | 23 (19.2%) | 2 (1.7%) | 21 (17.5%) |
| LARYNX | 19 (15.8%) | 1 (0.8%) | 18 (15.0%) |
| HYPOPHARYNX | 8 (6.7%) | 0 (0%) | 8 (6.7%) |
| OTHERS | 3 (2.5%) | 1 (0.8%) | 2 (1.7%) |
| **Tobacco Use (No.) | |||
| Never/Light Smoker (<10 pack years) | 54 (45.0%) | 33 (27.5%) | 21 (17.5%) |
| Heavy Smoker (≥10 pack years) | 66 (55.0%) | 18 (15.0%) | 48 (40.0%) |
| Alcohol Use (No.) | |||
| Never/Light Drinker | 49 (40.8%) | 26 (21.7%) | 23 (19.1%) |
| Heavy Drinker | 71 (59.2%) | 25 (20.8%) | 46 (38.4%) |
| *T Stage (No.) | |||
| Small primary (T1–2) | 39 (32.5%) | 23 (19.2%) | 16 (13.3%) |
| Large Primary (T3–4) | 81 (67.5%) | 28 (23.3%) | 53 (44.2%) |
| N Stage (No.) | |||
| 0–1 | 20 (16.7%)**** | 5 (4.2%) | 15 (12.5%) |
| 2–3 | 100 (83.3%) | 46 (38.3%) | 54 (45.0%) |
| Clinical Stage (No.) | |||
| I–III | 5 (4.2%) | 3 (2.5%) | 2 (1.7%) |
| IV | 115 (95.8%) | 48 (40.0%) | 67 (55.8%) |